Lambert A P, Hunt M A, Day A P, Bayly G R, Dayan C M
Department of Medicine, Weston General Hospital, Weston-super-Mare, UK.
Diabet Med. 2002 Jun;19(6):514-7. doi: 10.1046/j.1464-5491.2002.00687.x.
To determine prospectively, the reproducibility of individualized coronary heart disease (CHD) risk estimations in a high-risk (diabetic) population.
One hundred and three patients attending a hospital diabetes clinic who were in the primary prevention category for CHD had measurements of cholesterol, HDL-cholesterol and systolic blood pressure (SBP) performed in one of 13 general practices and then 2 weeks later in the hospital clinic. The data were combined with age, sex, smoking history and diabetic status data to produce a 10-year CHD risk estimate for each occasion using the Framingham algorithm.
The coefficients of variation for cholesterol, HDL and SBP were 6.0%, 9.4% and 7.0%, respectively. When classified by treatment thresholds of 15% and 30% 10-year CHD risk, 88% of patients were classified in the same category on both occasions. Kappa values for the 15% and 30% risk thresholds were 0.71 and 0.82. This indicates good interobserver agreement for the estimation of CHD risk. The use of a single BP rather than the mean of two, resulted in seven of 206 estimations of CHD risk performed in 103 patients crossing a risk threshold, with 6/7 being placed in a higher risk category.
Estimation of CHD risk on a single occasion is sufficient to make robust treatment decisions based on risk thresholds. Use of a single BP measurement rather than the mean of two overestimates the risk category in around 3% of cases.
前瞻性地确定在高危(糖尿病)人群中个性化冠心病(CHD)风险评估的可重复性。
103名在医院糖尿病门诊就诊且处于CHD一级预防阶段的患者,在13家普通诊所之一测量了胆固醇、高密度脂蛋白胆固醇和收缩压(SBP),然后在2周后在医院门诊再次测量。将这些数据与年龄、性别、吸烟史和糖尿病状态数据相结合,使用弗雷明汉算法对每次测量结果得出10年CHD风险评估。
胆固醇、高密度脂蛋白和收缩压的变异系数分别为6.0%、9.4%和7.0%。按照10年CHD风险的15%和30%治疗阈值进行分类时,88%的患者两次分类相同。15%和30%风险阈值的kappa值分别为0.71和0.82。这表明在CHD风险评估方面观察者间一致性良好。使用单次血压测量而非两次测量的平均值,导致在103名患者进行的206次CHD风险评估中有7次越过风险阈值,其中6/7被归为更高风险类别。
单次评估CHD风险足以基于风险阈值做出可靠的治疗决策。在约3%的病例中,使用单次血压测量而非两次测量的平均值会高估风险类别。